{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:58:53Z","timestamp":1772931533726,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2023,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The distribution of ovarian tumour characteristics differs between germline <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> pathogenic variant carriers and non-carriers. In this study, we assessed the utility of ovarian tumour characteristics as predictors of <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> variant pathogenicity, for application using the American College of Medical Genetics and the Association for Molecular Pathology (ACMG\/AMP) variant classification system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data for 10,373 ovarian cancer cases, including carriers and non-carriers of <jats:italic>BRCA1<\/jats:italic> or <jats:italic>BRCA2<\/jats:italic> pathogenic variants, were collected from unpublished international cohorts and consortia and published studies. Likelihood ratios (LR) were calculated for the association of ovarian cancer histology and other characteristics, with <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> variant pathogenicity. Estimates were aligned to ACMG\/AMP code strengths (supporting, moderate, strong).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No histological subtype provided informative ACMG\/AMP evidence in favour of <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> variant pathogenicity. Evidence against variant pathogenicity was estimated for the mucinous and clear cell histologies (supporting) and borderline cases (moderate). Refined associations are provided according to tumour grade, invasion and age at diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We provide detailed estimates for predicting <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> variant pathogenicity based on ovarian tumour characteristics. This evidence can be combined with other variant information under the ACMG\/AMP classification system, to improve classification and carrier clinical management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-023-02263-5","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T19:02:39Z","timestamp":1681930959000},"page":"2283-2294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2"],"prefix":"10.1038","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7212-0920","authenticated-orcid":false,"given":"Denise G.","family":"O\u2019Mahony","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0005-7798","authenticated-orcid":false,"given":"Susan J.","family":"Ramus","sequence":"additional","affiliation":[]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9134-2118","authenticated-orcid":false,"given":"Nicola S.","family":"Meagher","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Hadjisavvas","sequence":"additional","affiliation":[]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[]},{"given":"Evgeny N.","family":"Imyanitov","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4226-6435","authenticated-orcid":false,"given":"Irene L.","family":"Andrulis","sequence":"additional","affiliation":[]},{"given":"Priyanka","family":"Sharma","sequence":"additional","affiliation":[]},{"given":"Mary B.","family":"Daly","sequence":"additional","affiliation":[]},{"given":"Christopher R.","family":"Hake","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-092X","authenticated-orcid":false,"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-0501","authenticated-orcid":false,"given":"Anna","family":"Jakubowska","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-9580","authenticated-orcid":false,"given":"Andrew K.","family":"Godwin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-886X","authenticated-orcid":false,"given":"Adalgeir","family":"Arason","sequence":"additional","affiliation":[]},{"given":"Anita","family":"Bane","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6906-3390","authenticated-orcid":false,"given":"Jacques","family":"Simard","sequence":"additional","affiliation":[]},{"given":"Penny","family":"Soucy","sequence":"additional","affiliation":[]},{"given":"Maria A.","family":"Caligo","sequence":"additional","affiliation":[]},{"given":"Phuong L.","family":"Mai","sequence":"additional","affiliation":[]},{"given":"Kathleen B. M.","family":"Claes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-5982","authenticated-orcid":false,"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-5685","authenticated-orcid":false,"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[]},{"given":"Conxi","family":"Lazaro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8397-4078","authenticated-orcid":false,"given":"Peter J.","family":"Hulick","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-1792","authenticated-orcid":false,"given":"Amanda E.","family":"Toland","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-8040","authenticated-orcid":false,"given":"Inge Sokilde","family":"Pedersen","sequence":"additional","affiliation":[]},{"name":"HEBON Investigators","sequence":"additional","affiliation":[]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-0390","authenticated-orcid":false,"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-5137","authenticated-orcid":false,"given":"Ana","family":"Vega","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-1410","authenticated-orcid":false,"given":"Miguel","family":"de la Hoya","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-2976","authenticated-orcid":false,"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[]},{"given":"Mallika","family":"Dhawan","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Zampiga","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Danesi","sequence":"additional","affiliation":[]},{"given":"Liliana","family":"Varesco","sequence":"additional","affiliation":[]},{"given":"Viviana","family":"Gismondi","sequence":"additional","affiliation":[]},{"given":"Valerio Gaetano","family":"Vellone","sequence":"additional","affiliation":[]},{"given":"Paul A.","family":"James","sequence":"additional","affiliation":[]},{"given":"Ramunas","family":"Janavicius","sequence":"additional","affiliation":[]},{"given":"Liene","family":"Nikitina-Zake","sequence":"additional","affiliation":[]},{"given":"Finn Cilius","family":"Nielsen","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"van Overeem Hansen","sequence":"additional","affiliation":[]},{"given":"Tanja","family":"Pejovic","sequence":"additional","affiliation":[]},{"given":"Ake","family":"Borg","sequence":"additional","affiliation":[]},{"given":"Johanna","family":"Rantala","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Montagna","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-0901","authenticated-orcid":false,"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[]},{"given":"Susan M.","family":"Domchek","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8124-3984","authenticated-orcid":false,"given":"Ana","family":"Osorio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-9912","authenticated-orcid":false,"given":"Mar\u00eda J.","family":"Garc\u00eda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-2933","authenticated-orcid":false,"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[]},{"name":"GEMO Study Collaborators","sequence":"additional","affiliation":[]},{"given":"Fabienne","family":"Lesueur","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-4744","authenticated-orcid":false,"given":"Anna","family":"De Fazio","sequence":"additional","affiliation":[]},{"given":"David","family":"Bowtell","sequence":"additional","affiliation":[]},{"name":"AOCS Group","sequence":"additional","affiliation":[]},{"given":"Anna","family":"De Fazio","sequence":"additional","affiliation":[]},{"given":"Lesley","family":"McGuffog","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5756-6222","authenticated-orcid":false,"given":"Goska","family":"Leslie","sequence":"additional","affiliation":[]},{"given":"Michael T.","family":"Parsons","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-0282","authenticated-orcid":false,"given":"Thilo","family":"D\u00f6rk","sequence":"additional","affiliation":[]},{"given":"Lisa-Marie","family":"Speith","sequence":"additional","affiliation":[]},{"given":"Elizabeth Santana","family":"dos Santos","sequence":"additional","affiliation":[]},{"given":"Alexandre Andr\u00e9 B. A.","family":"da Costa","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Radice","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6951-6855","authenticated-orcid":false,"given":"Paolo","family":"Peterlongo","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Papi","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Hahnen","sequence":"additional","affiliation":[]},{"given":"Rita K.","family":"Schmutzler","sequence":"additional","affiliation":[]},{"given":"Barbara","family":"Wappenschmidt","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-3247","authenticated-orcid":false,"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-0027","authenticated-orcid":false,"given":"Christian F.","family":"Singer","sequence":"additional","affiliation":[]},{"given":"Yen Yen","family":"Tan","sequence":"additional","affiliation":[]},{"given":"Alice S.","family":"Whittemore","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-1190","authenticated-orcid":false,"given":"Weiva","family":"Sieh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5738-6683","authenticated-orcid":false,"given":"James D.","family":"Brenton","sequence":"additional","affiliation":[]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[]},{"given":"Florentia","family":"Fostira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0470-0309","authenticated-orcid":false,"given":"Irene","family":"Konstantopoulou","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2413-1542","authenticated-orcid":false,"given":"Jana","family":"Soukupova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-657X","authenticated-orcid":false,"given":"Michal","family":"Vocka","sequence":"additional","affiliation":[]},{"name":"CZECANCA Consortium","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-732X","authenticated-orcid":false,"given":"Paul D. P.","family":"Pharoah","sequence":"additional","affiliation":[]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[]},{"given":"David E.","family":"Goldgar","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-7897","authenticated-orcid":false,"given":"Amanda B.","family":"Spurdle","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-1237","authenticated-orcid":false,"given":"Kyriaki","family":"Michailidou","sequence":"additional","affiliation":[]},{"name":"The Consortium of Investigators of Modifiers of BRCA1\/2","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"de la Hoya","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"van Overeem Hansen","sequence":"additional","affiliation":[]},{"given":"Elizabeth Santana","family":"dos Santos","sequence":"additional","affiliation":[]},{"name":"Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"2263_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","volume":"20","author":"R Sankaranarayanan","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207\u201325.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2263_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","volume":"23","author":"JD Seidman","year":"2004","unstructured":"Seidman JD, Horkayne-Szakaly I, Haiba M, Boice CR, Kurman RJ, Ronnett BM. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004;23:41\u20134.","journal-title":"Int J Gynecol Pathol"},{"key":"2263_CR3","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds). WHO classification of tumours of female reproductive organs, 4th edn. Lyon, France: International Agency for Research on Cancer; 2014."},{"key":"2263_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"IeM Shih","year":"2004","unstructured":"Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511\u20138.","journal-title":"Am J Pathol"},{"key":"2263_CR5","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M K\u00f6bel","year":"2008","unstructured":"K\u00f6bel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008;5:e232.","journal-title":"PLoS Med"},{"key":"2263_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"2263_CR7","doi-asserted-by":"publisher","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","volume":"107","author":"SJ Ramus","year":"2015","unstructured":"Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, et al. Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer. J Natl Cancer Inst. 2015;107:djv214.","journal-title":"J Natl Cancer Inst"},{"key":"2263_CR8","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","volume":"33","author":"H Song","year":"2015","unstructured":"Song H, Dicks E, Ramus SJ, Tyrer JP, Intermaggio MP, Hayward J, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. J Clin Oncol. 2015;33:2901\u20137.","journal-title":"J Clin Oncol"},{"key":"2263_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","volume":"147","author":"J Lilyquist","year":"2017","unstructured":"Lilyquist J, LaDuca H, Polley E, Davis BT, Shimelis H, Hu C, et al. Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. Gynecol Oncol. 2017;147:375\u201380.","journal-title":"Gynecol Oncol"},{"key":"2263_CR10","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","volume":"10","author":"SR Lakhani","year":"2004","unstructured":"Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004;10:2473\u201381.","journal-title":"Clin Cancer Res"},{"key":"2263_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","volume":"120","author":"KA Schrader","year":"2012","unstructured":"Schrader KA, Hurlburt J, Kalloger SE, Hansford S, Young S, Huntsman DG, et al. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstet Gynecol. 2012;120:235\u201340.","journal-title":"Obstet Gynecol"},{"key":"2263_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","volume":"40","author":"S Malander","year":"2004","unstructured":"Malander S, Ridderheim M, M\u00e5sb\u00e4ck A, Loman N, Kristoffersson U, Olsson H, et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer. 2004;40:422\u20138.","journal-title":"Eur J Cancer"},{"key":"2263_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3332\/ecancer.2016.639","volume":"10","author":"N Biglia","year":"2016","unstructured":"Biglia N, Sgandurra P, Bounous VE, Maggiorotto F, Piva E, Pivetta E, et al. Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival. Ecancermedicalscience. 2016;10:639.","journal-title":"Ecancermedicalscience."},{"key":"2263_CR14","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","volume":"23","author":"H Song","year":"2014","unstructured":"Song H, Cicek MS, Dicks E, Harrington P, Ramus SJ, Cunningham JM, et al. The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Hum Mol Genet. 2014;23:4703\u20139.","journal-title":"Hum Mol Genet"},{"key":"2263_CR15","first-page":"1229","volume":"52","author":"SI Kim","year":"2020","unstructured":"Kim SI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, et al. Germline and somatic BRCA1\/2 gene mutational status and clinical outcomes in epithelial peritoneal, ovarian, and fallopian tube cancer: over a decade of experience in a single institution in Korea. Cancer Res Treat. 2020;52:1229\u201341.","journal-title":"Cancer Res Treat"},{"key":"2263_CR16","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1158\/1078-0432.CCR-07-4806","volume":"14","author":"M Soegaard","year":"2008","unstructured":"Soegaard M, Kjaer SK, Cox M, Wozniak E, H\u00f8gdall E, H\u00f8gdall C, et al. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res. 2008;14:3761\u20137.","journal-title":"Clin Cancer Res"},{"key":"2263_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/jmedgenet-2018-105930","volume":"56","author":"J Hauke","year":"2019","unstructured":"Hauke J, Hahnen E, Schneider S, Reuss A, Richters L, Kommoss S, et al. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883). J Med Genet. 2019;56:574\u201380.","journal-title":"J Med Genet"},{"key":"2263_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482\u201390.","journal-title":"JAMA Oncol"},{"key":"2263_CR19","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/cncr.21536","volume":"104","author":"T Pal","year":"2005","unstructured":"Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104:2807\u201316.","journal-title":"Cancer."},{"key":"2263_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19:77\u2013102.","journal-title":"J Natl Compr Canc Netw"},{"key":"2263_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1200\/JCO.19.02960","volume":"38","author":"PA Konstantinopoulos","year":"2020","unstructured":"Konstantinopoulos PA, Norquist B, Lacchetti C, Armstrong D, Grisham RN, Goodfellow PJ, et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. J Clin Oncol. 2020;38:1222\u201345.","journal-title":"J Clin Oncol"},{"key":"2263_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejca.2016.03.009","volume":"61","author":"M Arts-de Jong","year":"2016","unstructured":"Arts-de Jong M, de Bock GH, van Asperen CJ, Mourits MJ, de Hullu JA, Kets CM. Germline BRCA1\/2 mutation testing is indicated in every patient with epithelial ovarian cancer: a systematic review. Eur J Cancer. 2016;61:137\u201345.","journal-title":"Eur J Cancer"},{"key":"2263_CR23","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00508-015-0814-7","volume":"127","author":"C Marth","year":"2015","unstructured":"Marth C, Hubalek M, Petru E, Polterauer S, Reinthaller A, Schauer C, et al. AGO Austria recommendations for genetic testing of patients with ovarian cancer. Wien Klin Wochenschr. 2015;127:652\u20134.","journal-title":"Wien Klin Wochenschr"},{"key":"2263_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-9-116","volume":"9","author":"SM Panchal","year":"2008","unstructured":"Panchal SM, Ennis M, Canon S, Bordeleau LJ. Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet. 2008;9:116.","journal-title":"BMC Med Genet"},{"key":"2263_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/GIM.0b013e318226fc15","volume":"13","author":"ML Murray","year":"2011","unstructured":"Murray ML, Cerrato F, Bennett RL, Jarvik GP. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med. 2011;13:998\u20131005.","journal-title":"Genet Med"},{"key":"2263_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/pon.1311","volume":"17","author":"J Vos","year":"2008","unstructured":"Vos J, Otten W, van Asperen C, Jansen A, Menko F, Tibben A. The counsellees\u2019 view of an unclassified variant in BRCA1\/2: recall, interpretation, and impact on life. Psychooncology. 2008;17:822\u201330.","journal-title":"Psychooncology"},{"key":"2263_CR27","doi-asserted-by":"publisher","first-page":"viii69","DOI":"10.1093\/annonc\/mdt312","volume":"24","author":"S Richter","year":"2013","unstructured":"Richter S, Haroun I, Graham TC, Eisen A, Kiss A, Warner E. Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling. Ann Oncol. 2013;24:viii69\u2013viii74.","journal-title":"Ann Oncol"},{"key":"2263_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/humu.22956","volume":"37","author":"S Moghadasi","year":"2016","unstructured":"Moghadasi S, Eccles DM, Devilee P, Vreeswijk MP, van Asperen CJ. Classification and clinical management of variants of uncertain significance in high penetrance cancer predisposition genes. Hum Mutat. 2016;37:331\u20136.","journal-title":"Hum Mutat"},{"key":"2263_CR29","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/annonc\/mdv278","volume":"26","author":"DM Eccles","year":"2015","unstructured":"Eccles DM, Mitchell G, Monteiro AN, Schmutzler R, Couch FJ, Spurdle AB, et al. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol. 2015;26:2057\u201365.","journal-title":"Ann Oncol"},{"key":"2263_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2263_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med. 2008;10:294\u2013300.","journal-title":"Genet Med"},{"key":"2263_CR32","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","volume":"20","author":"SV Tavtigian","year":"2018","unstructured":"Tavtigian SV, Greenblatt MS, Harrison SM, Nussbaum RL, Prabhu SA, Boucher KM, et al. Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054\u201360.","journal-title":"Genet Med"},{"key":"2263_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet. 2004;75:535\u201344.","journal-title":"Am J Hum Genet"},{"key":"2263_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/humu.21628","volume":"33","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, et al. ENIGMA\u2013evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2012;33:2\u20137.","journal-title":"Hum Mutat"},{"key":"2263_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/humu.21627","volume":"33","author":"NM Lindor","year":"2012","unstructured":"Lindor NM, Guidugli L, Wang X, Vall\u00e9e MP, Monteiro AN, Tavtigian S, et al. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat. 2012;33:8\u201321.","journal-title":"Hum Mutat"},{"key":"2263_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1826","volume":"9","author":"PK Lovelock","year":"2007","unstructured":"Lovelock PK, Spurdle AB, Mok MT, Farrugia DJ, Lakhani SR, Healey S, et al. Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? Breast Cancer Res. 2007;9:R82.","journal-title":"Breast Cancer Res"},{"key":"2263_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1158\/1055-9965.EPI-13-0391","volume":"22","author":"M K\u00f6bel","year":"2013","unstructured":"K\u00f6bel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev. 2013;22:1677\u201386.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2263_CR38","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30:2654\u201363.","journal-title":"J Clin Oncol"},{"key":"2263_CR39","first-page":"2433","volume":"4","author":"A Berchuck","year":"1998","unstructured":"Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res. 1998;4:2433\u20137.","journal-title":"Clin Cancer Res"},{"key":"2263_CR40","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/IGC.0000000000000529","volume":"25","author":"MC Choi","year":"2015","unstructured":"Choi MC, Heo JH, Jang JH, Jung SG, Park H, Joo WD, et al. Germline mutations of BRCA1 and BRCA2 in Korean ovarian cancer patients: finding founder mutations. Int J Gynecol Cancer. 2015;25:1386\u201391.","journal-title":"Int J Gynecol Cancer"},{"key":"2263_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/1471-0528.15171","volume":"125","author":"K Rust","year":"2018","unstructured":"Rust K, Spiliopoulou P, Tang CY, Bell C, Stirling D, Phang T, et al. Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real-life experience. BJOG. 2018;125:1451\u20138.","journal-title":"BJOG."},{"key":"2263_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2307\/2531405","volume":"40","author":"PAR Koopman","year":"1984","unstructured":"Koopman PAR. Confidence intervals for the ratio of two binomial proportions. Biometrics. 1984;40:513\u20137.","journal-title":"Biometrics."},{"key":"2263_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih IeM, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16:267\u201382.","journal-title":"Adv Anat Pathol"},{"key":"2263_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/PAS.0000000000000550","volume":"40","author":"D Lim","year":"2016","unstructured":"Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA. Morphological and immunohistochemical reevaluation of tumors initially diagnosed as ovarian endometrioid carcinoma with emphasis on high-grade tumors. Am J Surg Pathol. 2016;40:302\u201312.","journal-title":"Am J Surg Pathol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02263-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T10:05:59Z","timestamp":1685959559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6,29]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1038\/s41416-023-02263-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research was approved by the Cyprus National Bioethics Committee (EEBK E\u03a0 2020.01.224). All clinically- and research-collected data were based on samples recruited by the host institutions under protocols approved by local ethics review boards at each participating institution and study group, consent form was obtained for each study participant. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}